were duplicated. The PKC immunoblot from Fig. 4B was reused in Fig. 5. In Fig. 5 , lanes 9 and 12 of the IRS-1 (IR-IRS-1 complex) immunoblot were duplicated. Additionally, lanes 1 and 8 and lanes 5, 10, and 11 of the IRS-1 (total) immunoblot were duplicated. In Fig. 6 , lanes 2 and 9 of the IRS-1 immunoblot were duplicated. The withdrawing authors state that these presentational errors do not impact the underlying scientific findings of the article, which are also presented as quantitative bar graphs that essentially summarize data of a number of experiments. Therefore, the withdrawing authors stand by the original scientific results as described, which in the authors' opinion has been confirmed in other laboratories (Moeschel, K., Beck, A., Weigert, C., Lammers, R., Kalbacher, H., Voelter, W., Schleicher, E. D., Häring, H.-U., and Lehmann, R. (2004) Protein kinase C--induced phosphorylation of Ser 318 in insulin receptor substrate-1 (IRS-1) attenuates the interaction with the insulin receptor and the tyrosine phosphorylation of IRS-1. Role of insulin receptor substrates and protein kinase C-in vascular permeability factor/ vascular endothelial growth factor expression in pancreatic cancer cells.
